Holdings of Empower T. Rowe Price Mid Cap Growth Fund
EMPOWER FUNDS, INC. · 114 declared positions · as of Mar 31, 2026
Original filing · Net assets 1.9B $ · Ten largest lines: 20.4 % of the equity sleeve
Sector breakdown
- Consumer discretionary 14.0 %
- Technology 13.1 %
- Health care 10.7 %
- Industrials 10.3 %
- Financials 4.3 %
- Energy 3.9 %
- Materials 2.7 %
- Consumer staples 0.8 %
- Communication 0.3 %
- Unattributed 39.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 98.9 %
- CAD 1.1 %
The quoted currency of each line, as declared.
Country breakdown
- US 92.1 %
- BM 2.0 %
- GB 1.8 %
- DK 0.8 %
- CA 0.8 %
- JE 0.7 %
- CH 0.7 %
- NL 0.6 %
- DE 0.4 %
- KY 0.1 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 104 | 1.7B $ | 92.11 % |
| BM | 1 | 37.3M $ | 2.02 % |
| GB | 1 | 32.9M $ | 1.78 % |
| DK | 1 | 14.9M $ | 0.81 % |
| CA | 1 | 14.1M $ | 0.76 % |
| JE | 1 | 13.6M $ | 0.74 % |
| CH | 2 | 12.1M $ | 0.66 % |
| NL | 1 | 11.2M $ | 0.61 % |
| DE | 1 | 7.8M $ | 0.42 % |
| KY | 1 | 1.8M $ | 0.10 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| CG oncology Inc | 62,839 | 4.3M $ | 0.22 % |
| Unity Software Inc | 188,614 | 4.1M $ | 0.22 % |
| CRISPR Therapeutics AG | 86,238 | 4.1M $ | 0.22 % |
| Ralliant Corp | 92,962 | 3.9M $ | 0.20 % |
| Caris Life Sciences Inc | 214,396 | 3.8M $ | 0.20 % |
| Kymera Therapeutics Inc | 44,949 | 3.7M $ | 0.20 % |
| McGraw Hill Inc | 263,834 | 3.6M $ | 0.19 % |
| Amphenol Corp | 27,966 | 3.5M $ | 0.19 % |
| DraftKings Inc | 161,882 | 3.5M $ | 0.18 % |
| Aurora Innovation Inc | 816,604 | 3.4M $ | 0.18 % |
| Revolution Medicines Inc | 29,300 | 2.8M $ | 0.15 % |
| QuidelOrtho Corp | 125,683 | 2.1M $ | 0.11 % |
| Nuvalent Inc | 19,546 | 2M $ | 0.11 % |
| Bullish | 51,716 | 1.8M $ | 0.10 % |